Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 144

1.

Esomeprazole alone compared with esomeprazole plus aspirin for the treatment of aspirin-related peptic ulcers.

Liu CP, Chen WC, Lai KH, Mar GY, Lin SY, Ger LP, Hsu PI; Formosa Acid-Related Disease (FARD) Study Group..

Am J Gastroenterol. 2012 Jul;107(7):1022-9. doi: 10.1038/ajg.2012.87.

PMID:
22508148
2.

Clopidogrel versus aspirin and esomeprazole to prevent recurrent ulcer bleeding.

Chan FK, Ching JY, Hung LC, Wong VW, Leung VK, Kung NN, Hui AJ, Wu JC, Leung WK, Lee VW, Lee KK, Lee YT, Lau JY, To KF, Chan HL, Chung SC, Sung JJ.

N Engl J Med. 2005 Jan 20;352(3):238-44.

3.

High-dose versus low-dose esomeprazole-based triple therapy for Helicobacter pylori infection.

Hsu PI, Lai KH, Wu CJ, Tseng HH, Tsay FW, Peng NJ, Chen TA, Chuah SK, Lin WS, Lo GH.

Eur J Clin Invest. 2007 Sep;37(9):724-30.

PMID:
17696962
4.

Esomeprazole with aspirin versus clopidogrel for prevention of recurrent gastrointestinal ulcer complications.

Lai KC, Chu KM, Hui WM, Wong BC, Hung WK, Loo CK, Hu WH, Chan AO, Kwok KF, Fung TT, Wong J, Lam SK.

Clin Gastroenterol Hepatol. 2006 Jul;4(7):860-5.

PMID:
16797240
5.

Comparative study of modified-release clarithromycin and immediate-release clarithromycin in the treatment of Helicobacter pylori-associated peptic ulcer disease.

Liou JM, Chen CY, Wu MS, Hsu MT, Fang CC, Lin YL, Chang MC, Lin JT, Wang HP.

Hepatogastroenterology. 2006 Sep-Oct;53(71):792-6.

PMID:
17086891
6.

Randomised clinical trial: esomeprazole for the prevention of nonsteroidal anti-inflammatory drug-related peptic ulcers in Japanese patients.

Sugano K, Kinoshita Y, Miwa H, Takeuchi T; Esomeprazole NSAID Preventive Study Group..

Aliment Pharmacol Ther. 2012 Jul;36(2):115-25. doi: 10.1111/j.1365-2036.2012.05133.x.

7.

Efficacy of esomeprazole (20 mg once daily) for reducing the risk of gastroduodenal ulcers associated with continuous use of low-dose aspirin.

Yeomans N, Lanas A, Labenz J, van Zanten SV, van Rensburg C, Rácz I, Tchernev K, Karamanolis D, Roda E, Hawkey C, Nauclér E, Svedberg LE.

Am J Gastroenterol. 2008 Oct;103(10):2465-73. doi: 10.1111/j.1572-0241.2008.01995.x.

PMID:
18637091
8.

Prevention of peptic ulcers with esomeprazole in patients at risk of ulcer development treated with low-dose acetylsalicylic acid: a randomised, controlled trial (OBERON).

Scheiman JM, Devereaux PJ, Herlitz J, Katelaris PH, Lanas A, Veldhuyzen van Zanten S, Nauclér E, Svedberg LE.

Heart. 2011 May;97(10):797-802. doi: 10.1136/hrt.2010.217547.

9.

[Effect of birid triple viable on peptic ulcer patients with Helicobacter pylori infection].

Xu C, Xiao L, Zou H.

Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2010 Sep;35(9):1000-4. doi: 10.3969/j.issn.1672-7347.2010.09.017. Chinese.

10.

Effect of esomeprazole triple therapy on eradication rates of Helicobacter pylori, gastric ulcer healing and prevention of relapse in gastric ulcer patients.

Tulassay Z, Stolte M, Sjölund M, Engstrand L, Butruk E, Malfertheiner P, Dite P, Tchernev K, Wong BC, Gottlow M, Eklund S, Wrangstadh M, Nagy P.

Eur J Gastroenterol Hepatol. 2008 Jun;20(6):526-36. doi: 10.1097/MEG.0b013e3282f427ac.

PMID:
18467912
12.

Celecoxib compared with lansoprazole and naproxen to prevent gastrointestinal ulcer complications.

Lai KC, Chu KM, Hui WM, Wong BC, Hu WH, Wong WM, Chan AO, Wong J, Lam SK.

Am J Med. 2005 Nov;118(11):1271-8.

PMID:
16271912
13.

Continuation of low-dose aspirin therapy in peptic ulcer bleeding: a randomized trial.

Sung JJ, Lau JY, Ching JY, Wu JC, Lee YT, Chiu PW, Leung VK, Wong VW, Chan FK.

Ann Intern Med. 2010 Jan 5;152(1):1-9. doi: 10.7326/0003-4819-152-1-201001050-00179.

PMID:
19949136
14.

Esomeprazole for prevention and resolution of upper gastrointestinal symptoms in patients treated with low-dose acetylsalicylic acid for cardiovascular protection: the OBERON trial.

Scheiman JM, Herlitz J, Veldhuyzen van Zanten SJ, Lanas A, Agewall S, Nauclér EC, Svedberg LE, Nagy P.

J Cardiovasc Pharmacol. 2013 Mar;61(3):250-7. doi: 10.1097/FJC.0b013e31827cb626.

PMID:
23188121
15.

Evaluation of Helicobacter pylori eradication by triple therapy plus Lactobacillus acidophilus compared to triple therapy alone.

Medeiros JA, Gonçalves TM, Boyanova L, Pereira MI, de Carvalho JN, Pereira AM, Cabrita AM.

Eur J Clin Microbiol Infect Dis. 2011 Apr;30(4):555-9. doi: 10.1007/s10096-010-1119-4.

PMID:
21207091
17.

Does eradication of Helicobacter pylori impair healing of nonsteroidal anti-inflammatory drug associated bleeding peptic ulcers? A prospective randomized study.

Chan FK, Sung JJ, Suen R, Lee YT, Wu JC, Leung WK, Chan HL, Lai AC, Lau JY, Ng EK, Chung SC.

Aliment Pharmacol Ther. 1998 Dec;12(12):1201-5.

18.

One week of treatment with esomeprazole-based triple therapy eradicates Helicobacter pylori and heals patients with duodenal ulcer disease.

Tulassay Z, Kryszewski A, Dite P, Kleczkowski D, Rudzinski J, Bartuzi Z, Hasselgren G, Larkö A, Wrangstadh M.

Eur J Gastroenterol Hepatol. 2001 Dec;13(12):1457-65.

PMID:
11742194
19.
20.

Randomised clinical trial: rabeprazole plus aspirin is not inferior to rabeprazole plus clopidogrel for the healing of aspirin-related peptic ulcer.

Luo JC, Huang KW, Leu HB, Chen LC, Hou MC, Li CP, Lu CL, Lin HC, Lee FY, Lee SD.

Aliment Pharmacol Ther. 2011 Sep;34(5):519-25. doi: 10.1111/j.1365-2036.2011.04760.x.

Items per page

Supplemental Content

Support Center